ALB and End Stage Liver Disease: Existing tools [Child-Pugh, model for end-stage liver disease (MELD), MELD-sodium (MELD-Na), Albumin-Bilirubin (ALBI), and platelet ALBI (PALBI)] have limitations, including subjectivity, complexity, and reliance on logarithmic transformations.